Legal

CAScination AG
Steigerhubelstrasse 3
CH-3008 Bern, Switzerland

Phone +41 31 552 04 40
Fax +41 31 552 04 41

info@CAScination.com

CEO
Dr. Matthias Peterhans 


Editorial Team 
CAScination AG 
Marketing Communication 

Disclaimer 
CAScination AG has taken the greatest possible care in creating this website. Nonetheless, we cannot exclude the possibility that it may contain errors. None of the information and recommendations given on this website may be construed as a basis for any claims against CAScination AG. Should statutory provisions stipulate liability, then such liability shall be limited to intent and gross negligence. The data relating to settings, application positions, application duration and the use of instruments is based on clinical tests. Such data is merely intended to provide guidelines, the applicability of which must be verified by the operator. Depending on circumstances, it may be necessary to deviate from the data provided on this website. Medical science is subject to a process of permanent change based on research and clinical experience. It may also be appropriate to deviate from the data provided here based on the results of such research and experience. 

Disclaimer - CAS-One IR and Cas-One Surgery are CE-marked and FDA cleared. CAS-One Laparoscopy is CE-marked (and not for sale in the US).

 


Credits

Text

Beyer LP, Pregler B, Nießen C, Schicho A, Haimerl M, Jung EM, et al. Stereotactically-navigated percutaneous Irreversible Electroporation (IRE) compared to conventional IRE: a prospective trial. PeerJ. PeerJ, Inc; 2016;4:e2277.

Tanis E, Nordlinger B, Mauer M, Sorbye H, van Coevorden F, Gruenberger T, et al. Local recurrence rates after radiofrequency ablation or resection of colorectal liver metastases. Analysis of the European Organisation for Research and Treatment of Cancer #40004 and #40983. Eur J Cancer. 2014 Mar;50(5):912–9. 

Ruers T, Punt C, Van Coevorden F, Pierie JPEN, Borel-Rinkes I, Ledermann JA, et al. Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004). Ann Oncol. Oxford University Press; 2012 Oct 1;23(10):2619–26. 

Engstrand J, Nilsson H, Jansson A, Isaksson B, Freedman J, Lundell L, et al. A multiple microwave ablation strategy in patients with initially unresectable colorectal cancer liver metastases – A safety and feasibility study of a new concept. Eur J Surg Oncol. 2014 Nov;40(11):1488–93. 

Beyer LP, Pregler B, Nießen C, Schicho A, Haimerl M, Jung EM, et al. Stereotactically-navigated percutaneous Irreversible Electroporation (IRE) compared to conventional IRE: a prospective trial. PeerJ. PeerJ, Inc; 2016;4:e2277. 

Wallach D, Toporek G, Weber S, Bale R, Widmann G. Comparison of freehand-navigated and aiming device-navigated targeting of liver lesions. Int J Med Robot Comput Assist Surg. 2014 Mar;10(1):35–43.

J. Engstrand, G. Toporek, P. Harbut, E. Jonas, H. Nilsson, and J. Freedman, “Stereotactic CT-Guided Percutaneous Microwave Ablation of Liver Tumors With the Use of High-Frequency Jet Ventilation: An Accuracy and Procedural Safety Study,” Am. J. Roentgenol., vol. 208, no. 1, pp. 193–200, Jan. 2017.

Huber T, Baumgart J, Peterhans M, Weber S, Heinrich S, Lang H. Die verschwundene Lebermetastase – Neues Einsatzgebiet für die computerassistierte 3D-navigierte laparoskopische Leberesektion? Z Gastroenterol. 2016 Jan 11;54(1):40–3. 

Beyer LP, Pregler B, Nießen C, Schicho A, Haimerl M, Jung EM, et al. Stereotactically-navigated percutaneous Irreversible Electroporation (IRE) compared to conventional IRE: a prospective trial. PeerJ. PeerJ, Inc; 2016;4:e2277. 

Statistics

Beyer et al 2016

Images

Products Overview, CAS-One IR, Header CAS-One Liver, Teaser Benefits Interventional Radiology, Header Benefits Interventional Radiology, Header Surgeons, Company Pages (except for the fotolia images mentioned below ) - © Moser Photography

Products Overview, CAS-One IR, Header CAS-One Liver, Teaser Benefits Interventional Radiology, Header Benefits Interventional Radiology, Header Surgeons  – Quelle: Insel Gruppe AG

Header benefits - © oatawa / Fotolia
Header forpatients –  © Pixabay
Header videos – © BillionPhotos.com / Fotolia
Header news – © sebra / Fotolia
Header network – © bagotaj / Fotolia
Header institutions – © sudok1 / Fotolia
Header congresses –  © rcfotostock / Fotolia
Header benefits testimonials - © sdecoret / Fotolia
Header proven technology - © rogerphoto / Fotolia
Header forpatients benefits - © Pixabay
Header subpages camera - © waranyu / Fotolia
Teaser forpatients testimonials  - © Emmanuele / Fotolia
Teaser institutions - © taa22 / Fotolia
Teaser patients - © Rido / Fotolia
Teaser internship - © poomsak / Fotolia
Teaser jobs - © alexlmx / Fotolia
Teaser congresses - © andy0man / Fotolia
Teaser company background - © taskin / Fotolia
Teaser news and mediacoverage - © sveta / Fotolia
Teaser forpatients background - © boygostockphoto / Fotolia
Teaser outcomes publications - © Sashkin / Fotolia
physician - #180060096 - © BillionPhotos.com / Fotolia
Teaser start outcomes - © Photographee.eu / Fotolia